Chronic liver disease (CLD) is associated with approximately two million annual deaths
worldwide and is an enormous health burden.[1, 2] The majority of liver-related outcomes …

Conclusions: While imaging-based noninvasive liver disease assessment appeared to have
higher accuracy than blood-based tests to detect CSPH, only 9 studies fit the a priori …

Abbreviations: ALD, alcohol-associated liver disease; APRI, aspartate aminotransferase–
platelet ratio index; ARFI, acoustic radiation force impulse; AUROC, area under the receiver …

Introduction Accurate and reliable diagnosis and monitoring of hepatic fibrosis is
increasingly important given the variable natural history in chronic liver disease (CLD) and …

Objectives To determine how fetuin-A contributes to diagnosing and assessing MASLD
severity. Methods Fifty MASLD patients and fifty healthy control participants were involved in …

Background There are no known non-invasive tests (NITs) designed for accurately detecting
metabolic dysfunction-associated steatohepatitis (MASH) with liver fibrosis stages F2-F3 …

Background Accurate staging of liver fibrosis (LF) is essential for clinical management in
chronic liver disease. While non-contrast MRI (NC-MRI) yields valuable information for liver …

In the meantime, while endorsing the definition and the criteria of MASLD, during the period
of transition from NAFLD to MASLD, researchers should not uncritically translate NAFLD to …

Nonalcoholic fatty liver disease (NAFLD) encompasses a broad range of conditions,
commencing with simple steatosis and progressing to non‐alcoholic steatohepatitis, with the …

Hepatitis B virus (HBV) infection causes acute and chronic hepatitis, compensated and
decompensated cirrhosis, and hepatocellular carcinoma worldwide. The actual status of …